The rationale for preventing cancer cachexia: targeting excessive fatty acid oxidation
- PMID: 27443316
- PMCID: PMC4957313
- DOI: 10.1186/s40880-016-0129-8
The rationale for preventing cancer cachexia: targeting excessive fatty acid oxidation
Abstract
Cachexia commonly occurs at the terminal stage of cancer and has largely unclear molecular mechanisms. A recent study published in Nature Medicine, entitled "Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia," reveals that cachectic cancer cells can secrete multiple cytokines that induce excessive fatty acid oxidation, which is responsible for muscle loss in cancer cachexia. Inhibition of fatty acid oxidation using etomoxir can increase muscle mass and body weight in cancer cachexia animal models. The usage of stable cachexia animal models is also discussed in this research highlight.
Keywords: Cachexia; Cancer; Fatty acid oxidation.
Figures
Comment on
-
Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.Nat Med. 2016 Jun;22(6):666-71. doi: 10.1038/nm.4093. Epub 2016 May 2. Nat Med. 2016. PMID: 27135739
References
-
- Xu BQ, Tu ZW, Tao YL, Liu ZG, Li XH, Yi W, et al. Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center. Chin J Cancer. 2016;35(1):37. doi: 10.1186/s40880-016-0098-y. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
